DS 1971
Alternative Names: DS-1971; DS-1971aLatest Information Update: 30 Oct 2021
Price :
$50 *
At a glance
- Originator Daiichi Sankyo Inc
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 27 Apr 2018 Discontinued - Phase-I for Pain (In volunteers) in United Kingdom (PO, Suspension)
- 27 Apr 2018 Discontinued - Phase-I for Pain (In volunteers) in United Kingdom (PO, Tablet)
- 28 Dec 2017 No recent reports of development identified for phase-I development in Pain(In volunteers) in United Kingdom (PO, Tablet)